
Xavier Forns
Cap de la UnitatPublicacions destacades
-
Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries
Autors:Referència: Journal Of Hepatology 2023. -
Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)
Autors:Referència: Gastroenterology 2022. -
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Autors:Referència: Journal Of Hepatology 2021. -
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Autors:Referència: Journal Of Hepatology 2020. -
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions in the near future
Autors:Referència: Journal Of Hepatology 2020. -
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: relevance of non-characterized nodules
Autors:Referència: Journal Of Hepatology 2019. -
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.
Autors:Referència: Journal Of Viral Hepatitis 2018. -
Shorter HBIG administration is not associated to HBV recurrence when receiving combined prophylaxis after liver transplantation.
Autors:Referència: Liver International 2018. -
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection.
Autors:Referència: Hepatology 2018. -
Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients.
Autors:Referència: Journal Of Hepatology 2018.
Projectes destacats
-
Estudio de la disfunción de la respuesta inmune adaptativa periférica e intrahepática en las diferentes fases de la hepatitis crónica por el virus de la hepatitis B
Investigador/a principal: Xavier Forns BernhardtFinançador: Instituto de Salud Carlos IIICodi: PI18/00079Durada: 01/01/2019 - 01/01/2022 -
Evaluación prospectiva de un modelo externalizado de consulta especializada con intervención educacional para reducir la reinfección por el virus de la hepatitis C en un centro de reducción de daños
Investigador/a principal: Xavier Forns BernhardtCodi: 2020I018Durada: 01/01/2021 - 31/12/2022 -
TherVacB: A therapeutic vaccine to cure hepatitis B
Investigador/a principal: Xavier Forns BernhardtCodi: 848223Durada: 01/01/2020 - 31/12/2024 -
Defining the best strategy for global HCV screening, linkage-to-care, education and prevention in PWID population and validation of a new diagnostic dried blood spot test
Investigador/a principal: Sabela Lens GarcíaCodi: IN-ES-987-5349Durada: 02/05/2018 - 31/03/2022